Cargando…
SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
Most tumors initially respond to cytotoxic treatments, but acquired resistance often follows. The tumor microenvironment (TME) is a major barrier to clinical success by compromising therapeutic efficacy, and pathological relevance of multiple soluble factors released by a therapeutically remodeled T...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994019/ https://www.ncbi.nlm.nih.gov/pubmed/26751775 http://dx.doi.org/10.1038/onc.2015.494 |